Phenoxybenzamine
Other Peripheral Vasodilators
- Drug class
- Other Peripheral Vasodilators
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 2
Overview
Phenoxybenzamine is an active pharmaceutical ingredient in the Other Peripheral Vasodilators group (C04AX). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 16, 2024 |
| GB United Kingdom | MHRA | 1 | April 10, 2026 |
USUnited States· FDA
1 product
Uses
INDICATION AND USAGE
Phenoxybenzamine hydrochloride capsules are indicated in the treatment of pheochromocytoma, to control episodes of hypertension and sweating. If tachycardia is excessive, it may be necessary to use a beta -blocking agent concomitantly.
How to take
GBUnited Kingdom· MHRA
1 product
Uses
Hypertensive episodes associated with Phaeochromocytoma.
How to take
Drug interactions
Known interactions involving Phenoxybenzamine. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 0be6a394-cd10-42… · revised January 16, 2024 [PDF]
- [2]MHRA (UK) · PL127620224 · revised April 10, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.